- Home
- INBX vs BLFS Comparison
INBX vs BLFS Comparison
Compare INBX & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBX | BLFS |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.7M | 923.5M |
| IPO Year | 2024 | 2013 |
Fundamental Metrics
Financial Performance| Metric | INBX | BLFS |
|---|---|---|
| Price | $103.07 | $25.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $150.00 | $32.00 |
| AVG Volume (30 Days) | 442.3K | ★ 519.2K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | $1,300,000.00 | ★ $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ N/A | $1,273.75 |
| Revenue Growth | ★ 550.00 | 16.97 |
| 52 Week Low | $12.80 | $17.86 |
| 52 Week High | $155.29 | $29.57 |
Technical Indicators
Market Signals| Indicator | INBX | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 45.50 | 66.04 |
| Support Level | $99.20 | $23.74 |
| Resistance Level | $153.14 | $26.39 |
| Average True Range (ATR) | 11.61 | 1.10 |
| MACD | -3.13 | 0.28 |
| Stochastic Oscillator | 7.41 | 87.16 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.